Status:
RECRUITING
Test of Aquatic Mobility of SMA Infants
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Infantile Spinal Muscular Atrophy
Eligibility:
All Genders
Up to 12 years
Phase:
NA
Brief Summary
Spinal muscular atrophy (SMA) is a genetic neurodegenerative disease impacting spinal cord motor neurons, leading to motor and respiratory issues and, ultimately, death. With emerging therapies, a nee...
Detailed Description
This is a multicenter research project coordinated by the Child Neuromuscular Unit at Raymond Poincaré Hospital. Additionally, two other pediatric neurology departments, part of the national neuromusc...
Eligibility Criteria
Inclusion
- Infants with muscle weakness (commonly referred to as floppy babies):
- Confirmed diagnosis of SMA through gene mutation or deletion (SMN1 gene).
- Receiving standard care.
- Age less than 12 years and a height of less than 90 cm at the time of inclusion.
- Patients enrolled in a social security scheme.
- Informed consent signed by both parents of the child and the investigator.
Exclusion
- Patients presenting with lesions in the spinal cord or conditions affecting the cardiorespiratory system.
- Patients covered under the French Aid in Health for Foreign People program (AME).
Key Trial Info
Start Date :
June 26 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06152302
Start Date
June 26 2025
End Date
June 1 2026
Last Update
November 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Infantile neuromuscular unity - Department of paediatric neurological care and intentive care unity, Raymond Poincaré Hospital - APHP
Garches, France, 92380